Advanced Biomed Inc (ADVB) Stock AnalysisADVBStock AnalysisAdvanced Biomed Inc

Advanced Biomed Inc. is a holding company that operates, through its subsidiary, Advanced Biomed Inc. (Taiwan). The Company is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, and treatment of cancer through the detection of circulating tumor cells and related tumor markers. It has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The Company offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip. It operates in the Healthcare sector.

Advanced Biomed Inc. is a good buy right now due to its recent price surge of 19.16% over the last 5 days, and a significant increase in net income to $6,857,921 in Q2 2026, indicating strong operational performance. The RSI is currently at 70.162, suggesting the stock is overbought but still showing momentum. However, a risk to consider is the negative EPS of -0.38 in Q3 2026, which indicates ongoing challenges in profitability.